🔍

NACLIND - NACL Industries

📊 NSE: NACLIND 🏢 Pesticides / Agrochemicals - Indian 📅 Last Updated: 12/14/2025 10:12

📢 Recent Corporate Announcements

NACL Industries Receives NSE and BSE Approval for Promoter Re-classification

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 27 Apr 2026, 06:43 PM

NACL Industries Limited has received formal approval from both the National Stock Exchange (NSE) and BSE Limited for the re-classification of Algavista Greentech Private Limited. The entity is being moved from the 'Promoter Group' category to the public category following the company's application in February 2026. Both exchanges issued their no-objection letters on April 27, 2026, confirming compliance with SEBI (LODR) Regulations. This is a standard regulatory procedure and does not impact the company's day-to-day operations.

NSE and BSE granted no-objection for re-classification on April 27, 2026.
Algavista Greentech Private Limited is officially removed from the Promoter Group.
The re-classification application was originally filed by the company on February 3, 2026.
The process was completed under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 No immediate action is required as this is a regulatory re-classification of a promoter entity. Investors should check the upcoming quarterly shareholding pattern to see the updated distribution between promoter and public holdings.

NACL Industries Opens Special Window for Physical Share Transfer Re-lodgement

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 19 Apr 2026, 12:01 PM

NACL Industries Limited has announced the opening of a special window for shareholders to re-lodge transfer requests for physical shares. This move is in strict compliance with the SEBI circular dated January 30, 2026, aimed at resolving pending physical share transfers. The company published formal advertisements regarding this process in Financial Express and Andhra Prabha on April 19, 2026. This is a procedural regulatory update and does not impact the company's financial fundamentals.

Opening of a special window for re-lodgement of transfer requests for physical shares.
Compliance with SEBI Circular No. HO/38/13/11(2) 2026-MIRSD-POD/1/3750/2026 dated January 30, 2026.
Newspaper advertisements published on April 19, 2026, in Financial Express and Andhra Prabha.
Action taken under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 Shareholders holding physical certificates should review the newspaper advertisements or contact the company's Registrar and Transfer Agent (RTA) to utilize this window. No action is required for investors holding shares in dematerialized form.

NACL Industries Submits SEBI Compliance Certificate for Q4 FY2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 13 Apr 2026, 07:10 PM

NACL Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The filing confirms that the Registrar and Share Transfer Agent, XL Softech Systems Ltd, has processed all dematerialization requests for the quarter and financial year ended March 31, 2026. The certificate verifies that physical share certificates were mutilated and cancelled after due verification, and the depositories' names were updated in the register of members within the 30-day timeline. This is a standard regulatory procedure to ensure the integrity of electronic shareholding records.

Compliance certificate issued for the fourth quarter and financial year ended March 31, 2026.
Registrar XL Softech Systems Ltd confirmed all dematerialization requests were handled within 30 days.
Physical share certificates were mutilated and cancelled as per SEBI guidelines.
Confirmation that securities comprised in the certificates are listed on the relevant stock exchanges.

💡 No action is required from investors as this is a routine administrative filing confirming standard regulatory compliance.

NACL Industries Clarifies Recent Share Price Movement to NSE

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 10 Apr 2026, 01:56 PM

NACL Industries Limited has responded to a surveillance query from the National Stock Exchange (NSE) regarding significant recent movements in its share price. The company clarified that it has been regularly complying with Regulation 30 of SEBI (LODR) Regulations, 2015, and has made all necessary disclosures in a timely manner. Management stated there is no undisclosed material information or impending announcement that could impact the stock's price or volume. The company maintains that the recent price volatility is purely market-driven and not linked to any internal corporate developments.

Responded to NSE surveillance query Ref. No.: NSE/CM/Surveillance/16760 dated April 09, 2026
Confirmed full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Stated no undisclosed material information or impending announcements exist that would affect price
Attributed recent share price and volume movement to purely market-driven factors
Reiterated commitment to prompt disclosure of any future material events

💡 As the company has denied any undisclosed material developments, investors should treat recent price volatility as market-driven or speculative. Exercise caution and focus on fundamental performance rather than short-term price fluctuations.

NACL Industries Announces Trading Window Closure from April 1, 2026, for Q4 and FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Mar 2026, 06:03 PM

NACL Industries Limited has notified the exchanges that its trading window will be closed starting April 1, 2026. This action is in accordance with SEBI (Prohibition of Insider Trading) Regulations for the upcoming Q4 and full-year financial results for the period ending March 31, 2026. The window will remain shut for all designated persons until 48 hours after the audited financial results are made public. The date for the board meeting to approve these results is yet to be finalized and will be shared in a separate intimation.

Trading window closure begins on April 1, 2026.
Covers Audited Standalone and Consolidated Financial Results for Q4 and FY 2025-26.
Reopening scheduled 48 hours after the financial results are declared.
Restriction applies to designated employees and connected persons under SEBI guidelines.

💡 This is a standard regulatory procedure with no direct impact on stock fundamentals. Investors should wait for the earnings release to assess the company's financial health and growth trajectory.

NACL Industries Allots 1.65 Lakh Equity Shares Under ESOS-2020 Scheme

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Mar 2026, 01:50 PM

NACL Industries Limited has allotted 1,65,000 equity shares of face value ₹1 each to employees who exercised their vested options under the ESOS-2020 Scheme. The weighted average exercise price for these shares is ₹66.67 per share, resulting in a total share capital increase. Following this allotment, the company's total paid-up equity share capital has risen to 23,41,78,330 shares. The new shares will rank pari-passu with existing equity shares in all respects.

Allotment of 1,65,000 equity shares upon exercise of vested options under the ESOS-2020 Scheme.
Weighted average exercise price of ₹66.67 per share, with a price range between ₹50 and ₹78.
Total paid-up equity share capital increased from 23,40,13,330 to 23,41,78,330 shares.
The equity dilution resulting from this specific allotment is approximately 0.07%.
The allotment was approved by the Nomination and Remuneration Committee on March 25, 2026.

💡 No action is required as this is a routine administrative allotment with negligible impact on share value or ownership structure. Investors should focus on the company's core business performance and upcoming quarterly earnings.

NACL Industries to Convert Rs 51.95 Cr Loan to Subsidiary into CCDs

🟡 NEUTRAL ⭐ 5/10

REGULATORY 📅 25 Mar 2026, 01:29 PM

NACL Industries has approved the conversion of an existing Rs 51.95 crore inter-corporate loan extended to its wholly-owned subsidiary, NACL Spec-Chem Limited, into Compulsorily Convertible Debentures (CCDs). This financial restructuring is intended to strengthen the subsidiary's capital base without requiring any fresh infusion of funds from the parent company. The loan will be converted into 5,195 CCDs with a face value of Rs 1,00,000 each. The transaction is being conducted at arm's length and follows SEBI's regulatory framework for related party transactions.

Conversion of Rs 51.95 crore existing inter-corporate loan into Compulsorily Convertible Debentures (CCDs).
Issuance of 5,195 CCDs to the parent company at a face value of Rs 1,00,000 per unit.
Target entity is NACL Spec-Chem Limited, a 100% wholly-owned subsidiary of NACL Industries.
The move involves no fresh cash outflow and is a restructuring of existing financial exposure.
CCDs will be compulsorily converted into equity shares of the subsidiary in the future.

💡 This is an internal capital restructuring between the parent and its subsidiary with no impact on consolidated cash flows. Investors should view this as a routine balance sheet optimization for the subsidiary.

NACL Industries Reports Nil Deviation in Utilization of ₹249.29 Crore Rights Issue Proceeds

🟡 NEUTRAL ⭐ 6/10

FUNDRAISE 📅 05 Feb 2026, 07:58 PM

NACL Industries has submitted its monitoring agency report for the quarter ended December 31, 2025, confirming zero deviation in the use of funds from its recent Rights Issue. The company raised approximately ₹249.29 crore through the issuance of 3.25 crore equity shares at ₹76.70 each. As the funds were raised on the final day of the quarter (December 31, 2025), no utilization occurred during the reporting period. The proceeds are earmarked primarily for debt repayment of the company and its subsidiary, NACL Spec-Chem Limited.

Raised a total of ₹24,928.91 lakhs through a Rights Issue completed on December 31, 2025.
Allocated ₹10,400 lakhs for repayment or prepayment of company borrowings.
Earmarked ₹8,300 lakhs for investment in subsidiary NACL Spec-Chem Limited to settle its outstanding debts.
CRISIL Ratings Limited, the monitoring agency, confirmed nil deviation from the objects stated in the Letter of Offer.
General corporate purposes and issue expenses account for the remaining ₹6,228.92 lakhs of the proceeds.

💡 Investors should track the upcoming quarterly reports to ensure the funds are effectively deployed for debt reduction as planned, which could improve the company's balance sheet strength. No immediate action is required as this is a routine regulatory compliance filing.

NACL Industries Reports Nil Deviation in ₹249.29 Crore Rights Issue Proceeds

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 05 Feb 2026, 07:52 PM

NACL Industries Limited has submitted its statement of deviation for the quarter ended December 31, 2025, regarding its recent Rights Issue. The company successfully raised ₹24,928.91 lakhs through the issuance of 3.25 crore equity shares at ₹76.70 each. As the allotment occurred on the final day of the quarter (December 31, 2025), the company reported zero utilization of funds during the period, resulting in nil deviation from the stated objects. The monitoring agency, CRISIL Ratings, confirmed that the proceeds are currently held in accordance with the offer document.

Raised ₹24,928.91 lakhs through a Rights Issue of 3,25,01,851 equity shares at ₹76.70 per share.
Reported Nil deviation or variation in the utilization of proceeds for the quarter ended December 31, 2025.
Allocated ₹10,400 lakhs for the repayment or prepayment of certain outstanding borrowings.
Planned investment of ₹8,300 lakhs in subsidiary NACL Spec-Chem Limited for debt repayment.
CRISIL Ratings Limited confirmed the status of funds as the appointed monitoring agency.

💡 This is a routine regulatory filing confirming that the Rights Issue proceeds are being handled as per the offer document; investors should monitor future quarters to ensure the planned debt reduction is executed.

NACL Industries Applies for Reclassification of Algavista Greentech to Public Category

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 03 Feb 2026, 11:42 AM

NACL Industries has submitted formal applications to BSE and NSE for the reclassification of Algavista Greentech Private Limited from the 'Promoter Group' to the 'Public' category. This follows the Board's approval on January 29, 2026, and a prior request on December 18, 2025. Significantly, the outgoing promoter entity currently holds zero shares (0.00%) in the company. This move is a procedural cleanup of the promoter group list under SEBI (LODR) Regulations.

Application submitted to BSE and NSE on February 02, 2026, for promoter reclassification.
Outgoing entity M/s Algavista Greentech Private Limited holds 0 equity shares (0.00% stake).
The reclassification process follows the Board of Directors' approval granted on January 29, 2026.
Action is compliant with Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 This is a routine administrative update with no impact on the company's financial health or actual control structure. No action is required from investors.

NACL Industries Shifts Registered and Corporate Offices in Hyderabad Effective Jan 28, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 30 Jan 2026, 11:09 PM

NACL Industries Limited has officially relocated both its Registered and Corporate offices within Hyderabad, effective January 28, 2026. The Registered Office has moved to Coromandel House in Secunderabad, while the Corporate Office is now situated at Pranava One in Somajiguda. This change follows a prior notification issued by the company on December 01, 2025. This is a purely administrative update and has no impact on the company's core business operations or financial health.

Registered Office shifted to Coromandel House, Secunderabad, Hyderabad - 500003
Corporate Office relocated to Pranava One, 17th Floor, Somajiguda, Hyderabad - 500082
The change in office addresses became effective from January 28, 2026
Update provided in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015

💡 No action is required from investors as this is a routine administrative relocation. Investors should update their records for any future physical correspondence with the company.

NACL Industries Reports Q3 FY26 Net Loss of ₹13.47 Crore; Losses Narrow YoY

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 30 Jan 2026, 12:39 PM

NACL Industries Limited has published its unaudited financial results for the third quarter ended December 31, 2025. The company reported a consolidated net loss of ₹13.47 crore for the quarter, which is a slight improvement compared to the ₹15.44 crore loss in the same period last year. Total income from operations for the quarter stood at ₹280.87 crore. Despite the narrowing of losses, the company remains in the red with a cumulative nine-month loss of ₹43.69 crore.

Consolidated Net Loss for Q3 FY26 narrowed to ₹13.47 crore from ₹15.44 crore in Q3 FY25.
Total Income from Operations for the quarter was reported at ₹280.87 crore.
Nine-month (9M FY26) consolidated net loss stands at ₹43.69 crore compared to ₹47.08 crore in 9M FY25.
Earnings Per Share (EPS) for the quarter remained negative at ₹(0.60) versus ₹(0.70) YoY.
Total Comprehensive Loss for the nine-month period ended December 2025 was ₹43.69 crore.

💡 Investors should exercise caution as the company continues to struggle with profitability despite a marginal year-on-year reduction in losses. Watch for signs of operational turnaround and improvement in the agrochemical industry's pricing environment.

NACL Industries to Invest ₹20 Cr in Subsidiary and Extend ₹55 Cr Loan at Lower Interest

🔵 WATCH ⭐ 7/10

BOARD_MEETING 📅 29 Jan 2026, 12:17 PM

NACL Industries has approved a ₹20 crore investment in its wholly-owned subsidiary, NACL Spec-Chem Limited, via Compulsorily Convertible Debentures (CCDs). The board also extended the tenure of a ₹55 crore inter-corporate loan to the same subsidiary by two years, while notably reducing the interest rate from 10% to 7.5%. Financial results for Q3 FY26 were approved, showing the subsidiary reported a net loss of ₹6.91 crore on revenue of ₹33.53 crore. Additionally, the company is seeking regulatory approval for the re-classification of Algavista Greentech Private Limited from the promoter group.

Investment of ₹20 crore in NACL Spec-Chem Limited through Compulsorily Convertible Debentures (CCDs).
Extension of ₹55 crore inter-corporate loan to the subsidiary for 2 years with interest rate reduced to 7.5% from 10%.
Subsidiary NACL Spec-Chem reported a net loss of ₹6.91 crore for the quarter ended December 31, 2025.
Board approved the re-classification request of Algavista Greentech Private Limited from the Promoter Group.
BSE imposed a fine of ₹55,000 for a delay in filing Related Party Transaction disclosures for H1 FY26.

💡 Investors should closely monitor the turnaround progress of NACL Spec-Chem, as the parent company is increasing its capital commitment while reducing its interest income from the subsidiary. The reduction in loan interest rates suggests a move to ease the subsidiary's financial burden at the cost of the parent's standalone margins.

NACL Industries Approves ₹20 Cr Investment in Subsidiary and Extends ₹55 Cr Loan

🟡 NEUTRAL ⭐ 7/10

BOARD_MEETING 📅 29 Jan 2026, 12:06 PM

NACL Industries has approved a ₹20 crore investment in its wholly-owned subsidiary, NACL Spec-Chem Limited, via Compulsorily Convertible Debentures (CCDs). The company also extended the tenure of an existing ₹55 crore inter-corporate loan to the same subsidiary by two years, while notably reducing the interest rate from 10% to 7.5%. Additionally, the board approved a re-classification request from promoter group entity Algavista Greentech Private Limited to the public category. The company also reported a minor regulatory fine of ₹55,000 from BSE for delayed related party transaction disclosures.

Approved ₹20 crore investment in subsidiary NACL Spec-Chem Limited through CCDs
Extended ₹55 crore inter-corporate loan tenure by 2 years with interest rate cut from 10% to 7.5%
Promoter group entity Algavista Greentech seeking re-classification to public category
BSE imposed a ₹55,000 fine for delayed submission of half-yearly related party transaction disclosures
Subsidiary NACL Spec-Chem reported a net loss of ₹6.91 crore for the quarter ended December 2025

💡 Investors should monitor the turnaround progress of NACL Spec-Chem, as the parent company is providing significant financial support and cheaper capital to manage its losses. The promoter re-classification and management changes appear routine but warrant observation regarding future shareholding patterns.

NACL Industries Approves Management Changes, ₹20 Cr Subsidiary Investment & Loan Restructuring

🟡 NEUTRAL ⭐ 7/10

BOARD_MEETING 📅 29 Jan 2026, 12:02 PM

NACL Industries has announced a series of strategic decisions following its board meeting on January 29, 2026. The company is increasing its commitment to its subsidiary, NACL Spec-Chem Limited, through a ₹20 crore CCD investment and a two-year extension of a ₹55 crore loan with a reduced interest rate of 7.5%. Management changes include designating Kannan Upadhyaya as Senior Management Personnel, while the board also approved a promoter re-classification request from Algavista Greentech. Additionally, the company addressed a minor ₹55,000 regulatory fine from BSE regarding delayed disclosures.

Approved ₹20 crore investment in subsidiary NACL Spec-Chem Limited via Compulsorily Convertible Debentures (CCDs).
Extended ₹55 crore inter-corporate loan to NACL Spec-Chem for 2 years, reducing the interest rate from 10% to 7.5%.
Designated Kannan Upadhyaya as Senior Management Personnel (SMP) following organizational changes.
Approved the re-classification request of Algavista Greentech Private Limited from 'Promoter Group' to 'Public' category.
Noted a ₹55,000 fine imposed by BSE for a delay in submitting related party transaction disclosures.

💡 Investors should monitor the impact of reduced interest income from the subsidiary loan and the progress of the ₹20 crore capital infusion into NACL Spec-Chem. The promoter re-classification and management shifts suggest internal restructuring that requires observation for long-term stability.

View All NACLIND Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue from operations for FY25 was INR 1,251.89 Cr, representing a 30% decrease compared to the previous year. However, H1 FY26 showed a recovery with revenue of INR 905.30 Cr, an 18.3% increase over INR 765.32 Cr in H1 FY25. The business is split between Technicals (Active Ingredients) and Formulations (60+ products), with the latter primarily serving the domestic retail market.

Geographic Revenue Split

NACL has a presence in 22 countries. While specific percentage splits per country are not provided, the company maintains a sizable export business with MNCs like Syngenta Asia Pacific and Nissan Chemical Corporation, alongside a vast domestic retail network in India.

Profitability Margins

Profitability was severely impacted in FY25 with a PAT margin of -7.56% (Loss of INR 92.13 Cr) compared to -3.34% in FY24. H1 FY26 saw a turnaround to a profit of INR 15.59 Cr. EBITDA margins are projected to recover to 8.0-9.0% in FY26 as price stabilization occurs.

EBITDA Margin

EBITDA for FY25 was a loss of INR 56.98 Cr, a significant decline from a positive EBITDA of INR 16.32 Cr in FY24. This represents a margin swing from approximately +0.9% to -4.5% YoY due to limited access to working capital and sectoral headwinds.

Capital Expenditure

The company is currently investing in de-bottlenecking capacities to support near-term growth. While the specific INR Cr for FY26 is not detailed, historical net worth grew from INR 350.53 Cr in FY20 to INR 577.41 Cr in FY23, indicating consistent asset base expansion.

Credit Rating & Borrowing

Credit rating was significantly upgraded to CRISIL AA/Stable/A1+ from BB+/A4+ following the acquisition by Coromandel International Limited (CIL). Borrowing costs are expected to decrease due to CIL's AAA rating and a proposed INR 160 Cr line of credit from the parent.

⚙️ Operational Drivers

Raw Materials

Active Ingredients (Technicals) and intermediates for generic molecules including insecticides, fungicides, and herbicides. Specific chemical names are not listed, but these represent the primary cost of goods sold.

Import Sources

Not specifically disclosed in the documents, though the company operates in the global generic molecule market which typically sources from China and domestic Indian suppliers.

Capacity Expansion

Current capacity utilization is approximately 70%. The company is implementing de-bottlenecking projects to increase throughput without massive greenfield spend, aiming to support a revenue target of INR 1,600-1,700 Cr in FY26.

Raw Material Costs

Raw material costs are a major component of the 30% revenue decline in FY25, as price volatility in generic molecules led to inventory write-downs and margin compression.

Manufacturing Efficiency

Capacity utilization stands at 70%. The company leverages cost-efficient manufacturing processes developed over three decades to compete with both organized and unorganized players.

Logistics & Distribution

The company operates a large retail dealer network across India to distribute its 66+ branded formulation products.

📈 Strategic Growth

Expected Growth Rate

32%

Growth Strategy

Growth will be driven by the acquisition by Coromandel International Limited (CIL), which provides financial flexibility and a line of credit of INR 160 Cr. The company plans to reach INR 1,600-1,700 Cr in revenue by FY26 through de-bottlenecking, launching new products from its R&D pipeline, and expanding its presence in 22 international markets.

Products & Services

Insecticides, fungicides, herbicides, and plant growth regulators sold as both Technicals (B2B) and Formulations (Retail).

Brand Portfolio

NACL (66+ branded products in the portfolio).

New Products/Services

The company has over 60 products covering all major crops and continues to develop new generic molecules to replace those facing patent expirations.

Market Expansion

Targeting deeper penetration in the domestic retail market and expanding the export footprint beyond the current 22 countries.

Strategic Alliances

Acquired by Coromandel International Limited (CIL), which now holds a 53.08% stake. NACL also holds a 26% stake in Nasense Labs Pvt Ltd.

🌍 External Factors

Industry Trends

The agrochemical industry is shifting toward innovation-led growth and digital adoption. NACL is positioning itself to benefit from upcoming patent expirations in the global market.

Competitive Landscape

Intense competition from organized regional players and unorganized local manufacturers in the generic segment.

Competitive Moat

Moat is based on 30+ years of manufacturing experience, long-standing relationships with global MNCs, and a strong brand in the domestic retail market. Sustainability is enhanced by the new parentage of the Murugappa Group (via CIL).

Macro Economic Sensitivity

Highly sensitive to agricultural GDP and farm income levels, which are dictated by monsoon performance.

Consumer Behavior

Farmers are increasingly looking for integrated pest management and plant growth regulators, shifting demand away from simple insecticides.

Geopolitical Risks

Trade barriers and changes in registration policies in international markets could impact the export of technical grade active ingredients.

⚖️ Regulatory & Governance

Industry Regulations

Operations are governed by the Insecticides Act, export/import policies, and product registration requirements in 22 countries. Changes in these can lead to product bans or mandatory reformulations.

Environmental Compliance

Subject to stringent environmental safety requirements and pollution norms for chemical manufacturing; specific ESG costs are not disclosed.

Taxation Policy Impact

The company is evaluating special tax benefits as of December 2025 in relation to its proposed Rights Issue.

Legal Contingencies

The company monitors potential provisions for doubtful debtors or write-offs, which impacted FY25 results, though specific litigation values are not provided.

⚠️ Risk Analysis

Key Uncertainties

Seasonality and rainfall distribution (impact up to 30% of revenue), regulatory changes in product safety, and volatility in raw material prices for generic molecules.